Hepatopulmonary Syndrome
Showing 1 - 25 of >10,000
Hepatopulmonary Syndrome (HPS) Trial in Beijing (Proteomic sequencing)
Recruiting
- Hepatopulmonary Syndrome (HPS)
- Proteomic sequencing
-
Beijing, ChinaNo.8, Xitoutiao, Youan Men Wai, Fengtai District
Jul 3, 2023
Hepatopulmonary Syndrome Trial in New Delhi (Pentoxifylline, Placebo)
Not yet recruiting
- Hepatopulmonary Syndrome
- Pentoxifylline
- Placebo
-
New Delhi, Delhi, IndiaInstitute of Liver & Biliary Sciences
May 9, 2022
Hepatopulmonary Syndrome Trial in San Francisco, Rochester (Letrozole, Placebo)
Recruiting
- Hepatopulmonary Syndrome
- Letrozole
- Placebo
-
San Francisco, California
- +1 more
Mar 23, 2022
Liver Cirrhosis Trial in New Delhi (Simvastatin 40mg, Placebo, Standard medical Treatment)
Recruiting
- Liver Cirrhosis
- Simvastatin 40mg
- +2 more
-
New Delhi, Delhi, IndiaInstitute of Liver & Biliary Sciences
Feb 28, 2022
Hepatopulmonary Syndrome (HPS) Trial in Rochester (Midodrine)
Completed
- Hepatopulmonary Syndrome (HPS)
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 5, 2021
Cirrhotic Patients With and Without Hepatocellular Carcinoma
Not yet recruiting
- Pulmonary Complications of Liver Cirrhosis and HCC
- spirometry
-
Sohag, EgyptSohag University hospitals
Jul 26, 2023
Hepatopulmonary Syndrome Trial in United States (Sorafenib, Placebo)
End Stage Liver DIsease Trial (sequential adolesent left lateral lobe liver transplantation (SALT))
Not yet recruiting
- End Stage Liver DIsease
- sequential adolesent left lateral lobe liver transplantation (SALT)
- (no location specified)
Oct 3, 2023
To Examine Whether Urinary Partial Oxygen Pressure Measurements
Not yet recruiting
- Acute Kidney Injury
- urinary partial oxygen pressure
- (no location specified)
Nov 7, 2023
Chronic Portal Vein Thrombosis in Children
Not yet recruiting
- Portal Vein Thrombosis
- endoscopy
- (no location specified)
Nov 3, 2023
HepatoCellular Carcinoma Trial in Taiwan (Atorvastatin, Placebo Oral Tablet)
Recruiting
- HepatoCellular Carcinoma
- Atorvastatin
- Placebo Oral Tablet
-
Chiayi City, Taiwan
- +5 more
Apr 26, 2022
Thromboelastography and Conventional Coagulation Tests in
Not yet recruiting
- Thromboelastography
- +2 more
- thromboelastography
- (no location specified)
Mar 30, 2023
Nerve; Disorder, Sympathetic, Healthy Trial
Enrolling by invitation
- Nerve; Disorder, Sympathetic
- Healthy
- (no location specified)
Mar 28, 2022
Congenital Porto-Systemic Shunt (CPSS) Trial in Worldwide (Shunt Closure)
Enrolling by invitation
- Congenital Porto-Systemic Shunt (CPSS)
- Shunt Closure
-
New Haven, Connecticut
- +27 more
Sep 11, 2023
Transjugular Intrahepatic Portosystemic Shunt on Oxygenation in
Completed
- Hepatopulmonary Syndrome
- Transjugular intrahepatic portosystemic shunt
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan university
Aug 28, 2018
Liver Cirrhosis Trial in New Delhi (Carvedilol, Pentoxifylline)
Not yet recruiting
- Liver Cirrhosis
-
New Delhi, Delhi, IndiaInstitute of Liver & Biliary Sciences.
Sep 16, 2023
Predictor of Clinical Endpoints in Pediatric Autoimmune Liver
Recruiting
- Autoimmune Liver Disease
- +2 more
-
Cincinnati, OhioCincinnati Children's Hospital and Medical Center
Feb 7, 2022
Colon Cancer, Liver Metastasis Colon Cancer, Rectal Cancer Trial in Ramat Gan (Hepatopulmonary radio-sterilization)
Not yet recruiting
- Colon Cancer
- +2 more
- Hepatopulmonary radio-sterilization
-
Ramat Gan, IsraelSheba Medical Center
Sep 21, 2023
Cirrhosis, Liver, Sarcopenia Trial in Portland (Transjugular Intrahepatic Portosystemic Shunt (TIPS) creation)
Recruiting
- Cirrhosis, Liver
- Sarcopenia
- Transjugular Intrahepatic Portosystemic Shunt (TIPS) creation
-
Portland, OregonOregon Health and Science University
Jun 13, 2022
Liver Failure, Acute on Chronic, Hepatic Encephalopathy, HBV Trial in Guangzhou (Rifaximin 200 mg, Standard Treatment without
Recruiting
- Liver Failure, Acute on Chronic
- +5 more
- Rifaximin 200 mg
- Standard Treatment without Rifaximin
-
Guangzhou, Guangdong, ChinaThe Third Affiliated Hospital of Sun Yat-sen University
Mar 26, 2023
Hypertension, Portal Trial in Philadelphia (SHAPE measurement using the ultrasound contrast agent Sonazoid (perfluorobutane
Recruiting
- Hypertension, Portal
- SHAPE measurement using the ultrasound contrast agent Sonazoid (perfluorobutane microbubbles)
- SHAPE measurement using the ultrasound contrast agent Lumason (sulfur hexafluoride lipid-type A microspheres)
-
Philadelphia, PennsylvaniaThe Children's Hospital of Philadelphia
Jan 20, 2022
Acute-On-Chronic Liver Failure, Renal Failure Trial in Freiburg (CytoSorb cytokine adsorber, CRRT)
Recruiting
- Acute-On-Chronic Liver Failure
- Renal Failure
- CytoSorb cytokine adsorber
- CRRT
-
Freiburg, GermanyUniversity Clinic Freiburg
Oct 30, 2021
Follow Up and Non-Invasive Diagnostics Program
Recruiting
- Vascular Disorder of Liver
- no intervention
-
Bonn, GermanyUniversity Hospital Bonn
Oct 4, 2021
Hepatopulmonary Syndrome in Cirrhosis Patients Caused by
Unknown status
- Hepatopulmonary Syndrome
-
Chongqing, Chongqing, ChinaDepartment of Anesthesiology, Southwest Hospital Third Military
Feb 9, 2018
Frailty, Cirrhosis, Liver Transplant Trial in Chicago ("LIver FrailTy" intervention (LIFT), "Realistic Effort Action Planning"
Recruiting
- Frailty
- +2 more
- "LIver FrailTy" intervention (LIFT)
- "Realistic Effort Action Planning" intervention (REAP)
-
Chicago, IllinoisNorthwestern Medicine
Apr 6, 2021